A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Efficacy of VLY-686 (Tradipitant) in Relieving Symptoms of Gastroparesis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 25 Aug 2017

At a glance

  • Drugs Tradipitant (Primary)
  • Indications Gastroparesis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Vanda Pharmaceuticals
  • Most Recent Events

    • 02 Aug 2017 According to a Vanda Pharmaceuticals media release, results are expected in the first half of 2018.
    • 15 Feb 2017 According to a Vanda Pharmaceuticals media release, results from the study are expected in the fourth quarter of 2017.
    • 31 Jan 2017 Planned End Date changed from 1 Aug 2017 to 1 Nov 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top